Publications (original articles or review articles) published in 2007 from OUS - Department of Cardiology Ullevaal (Div Med)
87 publications found
Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit
Am J Cardiol, 99 (10), 1357-9
DOI 10.1016/j.amjcard.2006.12.059, PubMed 17493459
Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure
J Hypertens, 25 (1), 15-23
DOI 10.1097/01.hjh.0000254378.26607.1f, PubMed 17143167
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population
Hypertension, 50 (3), 467-73
DOI 10.1161/HYPERTENSIONAHA.106.085654, PubMed 17679652
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Metabolism, 56 (11), 1470-7
DOI 10.1016/j.metabol.2007.06.012, PubMed 17950096
Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study
Neuropsychopharmacology, 32 (11), 2369-74
DOI 10.1038/sj.npp.1301355, PubMed 17356575
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action
J Hum Hypertens, 22 (1), 63-70
DOI 10.1038/sj.jhh.1002284, PubMed 17728797
The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
Stroke, 38 (3), 1069-71
DOI 10.1161/01.STR.0000258076.04860.8e, PubMed 17290027
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes
Am J Physiol Heart Circ Physiol, 293 (4), H2367-76
DOI 10.1152/ajpheart.01375.2006, PubMed 17660386
Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle
J Mol Cell Cardiol, 43 (6), 767-79
DOI 10.1016/j.yjmcc.2007.08.019, PubMed 17936780
Expression of mRNA encoding G protein-coupled receptors involved in congestive heart failure--a quantitative RT-PCR study and the question of normalisation
Basic Res Cardiol, 102 (3), 198-208
DOI 10.1007/s00395-007-0648-1, PubMed 17370034
A long-term follow-up study of chest pain patients: effect of panic disorder on mortality, morbidity, and quality of life
Cardiology, 110 (1), 8-14
DOI 10.1159/000109400, PubMed 17934263
The NORwegian study on DIstrict treatment of ST-elevation myocardial infarction (NORDISTEMI)
Scand Cardiovasc J, 41 (1), 32-8
DOI 10.1080/14017430601153472, PubMed 17365975
[Implantable loop recorders in evaluation of syncope]
Tidsskr Nor Laegeforen, 127 (12), 1657-9
PubMed 17571107
Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy)
Am J Cardiol, 101 (4), 510-5
DOI 10.1016/j.amjcard.2007.09.100, PubMed 18312768
Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Blood Press, 16 (1), 6-12
DOI 10.1080/08037050701246386, PubMed 17453746
Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor
FEBS J, 274 (9), 2411-23
DOI 10.1111/j.1742-4658.2007.05777.x, PubMed 17419735
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study
J Hum Hypertens, 21 (8), 625-32
DOI 10.1038/sj.jhh.1002203, PubMed 17476291
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy
Curr Med Res Opin, 23 (2), 259-70
DOI 10.1185/030079906X162854, PubMed 17288679
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
Metabolism, 56 (4), 464-9
DOI 10.1016/j.metabol.2006.11.003, PubMed 17379002
Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men
Br J Nutr, 99 (3), 674-81
DOI 10.1017/S0007114507832521, PubMed 17894919
Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials
Expert Rev Cardiovasc Ther, 5 (3), 451-61
DOI 10.1586/14779072.5.3.451, PubMed 17489670
Personality may influence reactivity to stress
Biopsychosoc Med, 1, 5
DOI 10.1186/1751-0759-1-5, PubMed 17371575
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study
J Intern Med, 262 (4), 439-48
DOI 10.1111/j.1365-2796.2007.01808.x, PubMed 17875180
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial
J Am Coll Cardiol, 49 (23), 2249-55
DOI 10.1016/j.jacc.2006.12.049, PubMed 17560289
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Atherosclerosis, 194 (1), 1-45
DOI 10.1016/j.atherosclerosis.2007.08.024, PubMed 17880983
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
Eur J Cardiovasc Prev Rehabil, 14 Suppl 2, E1-40
DOI 10.1097/01.hjr.0000277984.31558.c4, PubMed 17726406
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
Eur J Cardiovasc Prev Rehabil, 14 Suppl 2, S1-113
DOI 10.1097/01.hjr.0000277983.23934.c9, PubMed 17726407
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Eur Heart J, 28 (19), 2375-414
DOI 10.1093/eurheartj/ehm316, PubMed 17726041
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]
Rev Esp Cardiol, 60 (9), 968.e1-94
DOI 10.1157/13109650, PubMed 17915153
The evolution of ACE inhibition--a turning point in cardiovascular medicine
Blood Press Suppl, 2, 5-6
DOI 10.1080/08038020701538313, PubMed 18046972
Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction
Clin Physiol Funct Imaging, 27 (1), 60-6
DOI 10.1111/j.1475-097X.2007.00717.x, PubMed 17204040
Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives
Scand Cardiovasc J, 41 (5), 313-20
DOI 10.1080/14017430701411234, PubMed 17852781
Exceptional early blood pressure control rates: the ACCOMPLISH trial
Blood Press, 16 (2), 80-6
DOI 10.1080/08037050701395571, PubMed 17612905
Mechanism of troponin elevations in patients with acute ischemic stroke
Am J Cardiol, 99 (6), 867-70
DOI 10.1016/j.amjcard.2006.10.052, PubMed 17350385
The relation between electrocardiographic ST-T changes and NT-proBNP in patients with acute ischemic stroke
Scand Cardiovasc J, 41 (5), 294-8
DOI 10.1080/14017430701601644, PubMed 17886116
Effects of preload alterations on peak early diastolic mitral annulus velocities evaluated by tissue Doppler echocardiography
Eur J Anaesthesiol, 24 (2), 159-65
DOI 10.1017/S026502150600127X, PubMed 17202014
The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
J Cardiovasc Pharmacol, 49 (1), 27-32
DOI 10.1097/FJC.0b013e31802bdd8c, PubMed 17261960
Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study
BJOG, 114 (3), 279-88
DOI 10.1111/j.1471-0528.2006.01187.x, PubMed 17217362
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
Vasc Health Risk Manag, 3 (3), 299-305
PubMed 17703637
Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls
Diab Vasc Dis Res, 4 (1), 62-5
DOI 10.3132/dvdr.2007.009, PubMed 17469046
[Hyperbaric oxygen therapy for chronic diabetic wounds of the lower limbs--a review of the literature]
Harefuah, 146 (3), 223-7, 244-5
PubMed 17460932
Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial
J Psychosom Res, 62 (4), 411-8
DOI 10.1016/j.jpsychores.2006.11.010, PubMed 17383492
Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial
Am Heart J, 154 (4), 710.e1-8
DOI 10.1016/j.ahj.2007.07.003, PubMed 17892996
N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis
Kidney Int, 71 (6), 548-54
DOI 10.1038/sj.ki.5002087, PubMed 17299526
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension
J Hypertens, 25 (9), 1751-62
DOI 10.1097/HJH.0b013e3282f0580f, PubMed 17762635
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
J Hypertens, 25 (6), 1105-87
DOI 10.1097/HJH.0b013e3281fc975a, PubMed 17563527
Guidelines 2007 Guidelines for the treatment of hypertension by the Committee for the drafting of the Guidelines of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
G. Ital. Cardiol., 8 (7), 389-479
[Practice guidelines 2007 for the treatment of arterial hypertension]
G Ital Cardiol (Rome), 8 (7), 389-479
PubMed 17695132
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur Heart J, 28 (12), 1462-536
DOI 10.1093/eurheartj/ehm236, PubMed 17562668
2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Blood Press, 16 (3), 135-232
DOI 10.1080/08037050701461084, PubMed 17846925
Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure
J Mol Cell Cardiol, 43 (2), 177-86
DOI 10.1016/j.yjmcc.2007.05.004, PubMed 17574269
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study
Br J Cancer, 97 (1), 129-32
DOI 10.1038/sj.bjc.6603843, PubMed 17551490
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study
Vasc Med, 12 (4), 275-83
DOI 10.1177/1358863X07082720, PubMed 18048463
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients
Ann Intern Med, 147 (5), 311-9
DOI 10.7326/0003-4819-147-5-200709040-00006, PubMed 17785486
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
Hypertension, 50 (5), 984-90
DOI 10.1161/HYPERTENSIONAHA.107.096818, PubMed 17893425
Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice
Int J Clin Pract, 61 (9), 1481-91
DOI 10.1111/j.1742-1241.2007.01428.x, PubMed 17686092
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy
J Hypertens, 25 (3), 707-12
DOI 10.1097/HJH.0b013e3280147119, PubMed 17278988
Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo
Arterioscler Thromb Vasc Biol, 27 (7), 1587-95
DOI 10.1161/ATVBAHA.107.143081, PubMed 17525365
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study
Am J Cardiol, 99 (7), 970-3
DOI 10.1016/j.amjcard.2006.10.064, PubMed 17398194
The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension
Blood Press, 16 (2), 72-9
DOI 10.1080/08037050701338985, PubMed 17612904
Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials
Clin Chem Lab Med, 45 (4), 513-20
DOI 10.1515/CCLM.2007.108, PubMed 17439330
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease
J Thromb Thrombolysis, 25 (2), 207-13
DOI 10.1007/s11239-007-0047-3, PubMed 17530178
Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients
Cardiology, 107 (4), 307-12
DOI 10.1159/000099067, PubMed 17264511
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease
Am Heart J, 153 (3), 371-7
DOI 10.1016/j.ahj.2006.12.006, PubMed 17307414
Dyspnoea after antiplatelet agents: the AZD6140 controversy
Int J Clin Pract, 61 (3), 529-33
DOI 10.1111/j.1742-1241.2007.01294.x, PubMed 17313629
[Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction]
Lakartidningen, 104 (37), 2586-8
PubMed 17970392
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)
Am J Cardiol, 100 (5), 855-9
DOI 10.1016/j.amjcard.2007.03.109, PubMed 17719333
[Arginine vasopressin antagonism--new treatment option in chronic heart failure]
Tidsskr Nor Laegeforen, 127 (2), 179-82
PubMed 17237865
Improving care of patients at-risk for osteoporosis: a randomized controlled trial
J Gen Intern Med, 22 (3), 362-7
DOI 10.1007/s11606-006-0099-7, PubMed 17356969
LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts
Eur J Heart Fail, 9 (10), 1044-50
DOI 10.1016/j.ejheart.2007.07.013, PubMed 17719271
From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion
Blood Press, 16 (2), 87-94
DOI 10.1080/08037050701287703, PubMed 17612906
Increased hematocrit before blood pressure in men who develop hypertension over 20 years
J Am Soc Hypertens, 1 (6), 400-6
DOI 10.1016/j.jash.2007.07.002, PubMed 20409872
Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years
J Clin Hypertens (Greenwich), 9 (5), 365-71
DOI 10.1111/j.1524-6175.2007.06479.x, PubMed 17485972
Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest
Resuscitation, 73 (1), 29-39
DOI 10.1016/j.resuscitation.2006.08.016, PubMed 17258378
The Na+/K+-ATPase alpha2-isoform regulates cardiac contractility in rat cardiomyocytes
Cardiovasc Res, 75 (1), 109-17
DOI 10.1016/j.cardiores.2007.03.017, PubMed 17442282
The role of statins in patients with arterial hypertension
Arch. Med. Sci., 3 (4A), S97-S101
Do novel risk factors differ between men and women aged 18 to 39 years with a high risk of coronary heart disease?
Metabolism, 56 (2), 260-6
DOI 10.1016/j.metabol.2006.10.006, PubMed 17224342
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
Am J Cardiol, 99 (11), 1544-8
DOI 10.1016/j.amjcard.2007.01.030, PubMed 17531578
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation
Thromb Res, 121 (4), 447-53
DOI 10.1016/j.thromres.2007.06.014, PubMed 17698170
Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 Uncovers Distinct Functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness
J Biol Chem, 283 (16), 10601-10
DOI 10.1074/jbc.M708912200, PubMed 18165681
Rheumatic mitral valve stenosis mimicking advanced lung cancer
Heart Vessels, 22 (5), 345-8
DOI 10.1007/s00380-007-0979-8, PubMed 17879027
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study
Circulation, 116 (7), 700-5
DOI 10.1161/CIRCULATIONAHA.106.666594, PubMed 17664372
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk
Blood Press, 16 (1), 13-9
DOI 10.1080/08037050701217643, PubMed 17453747
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine
J Hum Hypertens, 21 (5), 374-80
DOI 10.1038/sj.jhh.1002159, PubMed 17314999
Access to and use of research by rural nurses
Rural Remote Health, 7 (3), 758
PubMed 17892348
[Congestive heart failure--etiology and diagnostic procedures]
Tidsskr Nor Laegeforen, 127 (2), 171-3
PubMed 17237863
[Treatment of congestive heart failure]
Tidsskr Nor Laegeforen, 127 (2), 174-7
PubMed 17237864